![Wayne Montgomery](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wayne Montgomery
Geen lopende functies
Profiel
Wayne Montgomery served as Vice President of Intellectual Property at Nektar Therapeutics, Chief Patent Counsel & Vice President at Axys Pharmaceuticals, Vice President of Patents at Exelixis, Vice President of Intellectual Property at Celera Group, and VP of Legal Affairs & Intellectual Property at iPierian, Inc. He holds a graduate degree from Santa Clara University and an undergraduate degree from the University of California, Santa Barbara.
Eerdere bekende functies van Wayne Montgomery
Bedrijven | Functie | Einde |
---|---|---|
Celera Group
![]() Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | - |
Axys Pharmaceuticals, Inc.
![]() Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
EXELIXIS, INC. | Corporate Officer/Principal | - |
NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
iPierian, Inc.
![]() iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA. | Algemeen Adviseur | - |
Opleiding van Wayne Montgomery
Santa Clara University | Graduate Degree |
University of California, Santa Barbara | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
EXELIXIS, INC. | Health Technology |
NEKTAR THERAPEUTICS | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
iPierian, Inc.
![]() iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA. | Health Technology |
Axys Pharmaceuticals, Inc.
![]() Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Celera Group
![]() Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |